Healios K.K.

¥223.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4593Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (19.71%)
Div yield —
ROE 4.25%
Biotechnology
Beta (5Y) 1.31
PE TTM —
TSR TTM (54.67%)
Mkt cap ¥30.23B
ROIC (129.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥258
15.56%
(54.07%)
Hold 8|0|3|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
2.32
2.30
2.46
2.57
11.32%
7.05%
19.74%
20.92%
Revenue¥B
3.087
3.180
3.090
3.146
2.47%
5.92%
0.90%
0.77%
Peers (US$191.9M)
Cap (US$)
PE
240.5M
10.86x
127.3M
—
192.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.123
(0.246)
(0.176)
EBIT/Intx
2.620
0.270
0.269
Own earn%
7.10
(6.20)
(26.72)
Sh yield%
44.40
22.65
23.02
Owners
Insiders/Inst%
7.14
55.87
Short interest%
1.39
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
20–25
$1 testx
0.5
Incr. ROIC%
4